{"id":599,"date":"2025-05-14T16:10:54","date_gmt":"2025-05-14T08:10:54","guid":{"rendered":"https:\/\/medicalsoho.com\/?p=599"},"modified":"2025-11-20T13:18:04","modified_gmt":"2025-11-20T05:18:04","slug":"brief-report-on-chinas-pharmaceutical-foreign-trade-in-the-first-quarter-of-2025","status":"publish","type":"post","link":"https:\/\/www.medicalsoho.com\/el\/brief-report-on-chinas-pharmaceutical-foreign-trade-in-the-first-quarter-of-2025\/","title":{"rendered":"\u03a3\u03cd\u03bd\u03c4\u03bf\u03bc\u03b7 \u0388\u03ba\u03b8\u03b5\u03c3\u03b7 \u03b3\u03b9\u03b1 \u03c4\u03bf \u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03cc \u0395\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u0395\u03bc\u03c0\u03cc\u03c1\u03b9\u03bf \u03c4\u03b7\u03c2 \u039a\u03af\u03bd\u03b1\u03c2 \u03c3\u03c4\u03bf \u03a0\u03c1\u03ce\u03c4\u03bf \u03a4\u03c1\u03af\u03bc\u03b7\u03bd\u03bf \u03c4\u03bf\u03c5 2025"},"content":{"rendered":"

In the first quarter of 2025, China\u2019s pharmaceutical and healthcare products import and export trade demonstrated characteristics of \u201cstable overall volume and optimized structure\u201d amid a complex and volatile international environment. Total trade volume reached US$47.088 billion, marking a slight year-on-year increase of 0.38%. Exports amounted to US$26.632 billion, up 4.39% year-on-year, primarily driven by sustained growth in traditional competitive products such as Western pharmaceutical raw materials and medical device consumables. Imports continued to contract, declining 4.42% year-on-year to US$20.456 billion, reflecting the import substitution effect resulting from domestic industrial upgrading. Structurally, Western pharmaceutical products dominated with a 54.4% share worth $25.605 billion. Among these, Western pharmaceutical raw materials exports reached $11.108 billion, up 5.19% year-on-year, with notable growth in hormone and vitamin subcategories. However, respiratory system drugs and penicillin-based products declined due to intensified international competition. Medical devices accounted for 41.5% of exports at $19.561 billion, growing 5.38% year-on-year. Low-value-added products like disposable consumables and medical dressings remained the mainstay of exports, while import substitution accelerated for high-end equipment, with hospital diagnostic and therapeutic equipment imports declining by 7.01%. Traditional Chinese medicine imports and exports totaled $1.943 billion, down 3.42% year-on-year, while extract exports reached $783 million, increasing by 9.35%.<\/p>\n

Export markets are showing increasing diversification. The United States, as the largest single market, saw exports reach $4.639 billion, up 9.6% year-on-year. Western pharmaceutical raw materials (vitamins, hormone intermediates) and disposable consumables (syringes, gloves) contributed the main growth. Total exports to the EU market amounted to $5.63 billion, up 4.43% year-on-year. Key countries like Germany saw procurement growth of 8.24%, while France declined by 5.5% and the Netherlands grew by 3.21%. Among emerging markets, exports to Belt and Road countries reached $10.88 billion, up 5.23% year-on-year, becoming a key growth engine. Russia saw a 12.54% increase and Saudi Arabia a 9.54% increase, driven by robust demand for medical infrastructure. Exports to the African market totaled $1.153 billion, growing by 11.18%. with Egypt growing by 29.37% and Nigeria by 24.03%, driven by significant increases in procurement of antimalarial drugs and basic consumables. Exports to South America grew by 11.1% year-on-year to $2.396 billion, with Brazil increasing by 17.14% and Argentina by 40.85%, as economic recovery and expanded healthcare coverage fueled growth in related pharmaceutical markets. Meanwhile, some markets showed weakness: exports to Japan fell by 2.93% and to South Korea by 6.68%. Exports to India grew by 7.54%, maintaining growth, but capacity expansion under India\u2019s policies to increase local supply of active pharmaceutical ingredients (APIs) may constrain China\u2019s API export growth in the future.<\/p>\n

The contraction in imports stems from the dual effects of accelerated substitution by domestically produced drugs and medical devices. Imports of Western medicines totaled $11.785 billion, down 2.03% year-on-year, while imports of raw materials bucked the trend with a 22.52% increase to $2.732 billion, driven by surging purchases of hormone intermediates and anti-infective raw materials. Medical device imports totaled $8.004 billion (-7.38%), with hospital diagnostic and therapeutic equipment imports declining by 7.01%, indicating accelerated substitution by domestically produced CT and MRI equipment. Reliance on imported high-end pharmaceuticals remains high\u2014anti-cancer drugs and rare disease medications still require sourcing from the EU and Switzerland\u2014though growth rates have slowed compared to previous years.<\/p>\n

Looking ahead, China\u2019s pharmaceutical trade will face a new normal characterized by intertwined opportunities and challenges. In the short term, Western pharmaceutical raw materials (such as vitamins and hormones) and medical device consumables will remain the main drivers of export growth, with demand for healthcare infrastructure in emerging markets like the Belt and Road Initiative and Africa continuing to expand. On the import side, the launch of domestically developed innovative drugs (such as PD-1 inhibitors) and breakthroughs in high-end equipment technology are expected to deepen the substitution process. Medium-to-long-term challenges warrant attention: the trend toward global supply chain diversification threatens China\u2019s advantage in active pharmaceutical ingredients (APIs), while the EU\u2019s Carbon Border Adjustment Mechanism (CBAM) and Medical Device Regulation (MDR) will increase compliance costs. Capacity expansion in India and Southeast Asia will intensify competitive pressures. Concurrently, technological barriers in high-end sectors like biologics and diagnostic equipment require urgent breakthroughs, and the internationalization of traditional Chinese medicine (TCM) still faces bottlenecks in standard certification and cultural acceptance. At the policy level, accelerating ESG framework development is essential to address green trade barriers. Optimizing logistics efficiency in emerging markets through infrastructure like China-Europe freight trains and overseas warehouses is crucial, alongside increasing support for innovative drug R to drive the transformation of pharmaceutical trade from \u201cscale-driven\u201d to \u201cvalue-driven.\u201d Overall, Q1 2025 data confirms China\u2019s resilience within the global pharmaceutical supply chain. However, how China consolidates its advantages and overcomes bottlenecks amid the wave of deglobalization will determine its future global standing in pharmaceutical trade.<\/p>\n

Statistics on China\u2019s Import and Export of Pharmaceutical and Health Products in the Global Market for January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

Top Ten Global Markets for China\u2019s Pharmaceutical Product Exports in January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

1\u3001Belt and Road Initiative<\/h2>\n

Statistics on China\u2019s Import and Export of Pharmaceutical and Health Products in the Belt and Road Markets for January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

Top Ten Markets for China\u2019s Pharmaceutical Product Exports Along the Belt and Road Initiative in January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

2\u3001European Union<\/h2>\n

Statistics on China\u2019s Import and Export of Pharmaceutical and Health Products in the EU Market from January to March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

Top Ten Markets for China\u2019s Pharmaceutical Product Exports to the EU in January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

3\u3001United States<\/h2>\n

Statistics on China\u2019s Import and Export of Pharmaceutical and Health Products in the U.S. Market for January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

4\u3001ASEAN<\/h2>\n

Statistics on China\u2019s Import and Export of Pharmaceutical and Health Products in the ASEAN Market for January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

Top Ten ASEAN Markets for China\u2019s Pharmaceutical Product Exports in January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

5\u3001Japan and South Korea<\/h2>\n

Statistics on China\u2019s Import and Export of Pharmaceutical and Health Products in the Japan and South Korea Markets for January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

6\u3001Latin America<\/h2>\n

Statistics on China\u2019s Import and Export of Pharmaceutical and Healthcare Products in the Latin American Market for January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

Top Ten Markets for China\u2019s Pharmaceutical Product Exports to Latin America in January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

7\u3001India<\/h2>\n

Statistics on China\u2019s Import and Export of Pharmaceutical and Health Products in the Indian Market for January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

8\u3001Africa<\/h2>\n

Statistics on China\u2019s Import and Export of Pharmaceutical and Healthcare Products in the African Market for January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

Top Ten African Markets for China\u2019s Pharmaceutical Product Exports in January-March 2025<\/strong><\/p>\n

\"Brief<\/p>\n

9\u3001Russia<\/h2>\n

\u03a3\u03c4\u03b1\u03c4\u03b9\u03c3\u03c4\u03b9\u03ba\u03ac \u03c3\u03c4\u03bf\u03b9\u03c7\u03b5\u03af\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03b9\u03c2 \u03b5\u03b9\u03c3\u03b1\u03b3\u03c9\u03b3\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03b5\u03be\u03b1\u03b3\u03c9\u03b3\u03ad\u03c2 \u03c6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ce\u03bd \u03ba\u03b1\u03b9 \u03c5\u03b3\u03b5\u03b9\u03bf\u03bd\u03bf\u03bc\u03b9\u03ba\u03ce\u03bd \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd\u03c4\u03c9\u03bd \u03c4\u03b7\u03c2 \u039a\u03af\u03bd\u03b1\u03c2 \u03c3\u03c4\u03b7 \u03c1\u03c9\u03c3\u03b9\u03ba\u03ae \u03b1\u03b3\u03bf\u03c1\u03ac \u03b3\u03b9\u03b1 \u03c4\u03bf \u03b4\u03b9\u03ac\u03c3\u03c4\u03b7\u03bc\u03b1 \u0399\u03b1\u03bd\u03bf\u03c5\u03b1\u03c1\u03af\u03bf\u03c5-\u039c\u03b1\u03c1\u03c4\u03af\u03bf\u03c5 2025<\/strong><\/p>\n

\"Brief<\/p>","protected":false},"excerpt":{"rendered":"

In the first quarter of 2025, China’s pharmaceutical and healthcare products import and export trade demonstrated characteristics of \u201cstable overall volume and optimized structure\u201d amid a complex and volatile international environment. Total trade volume reached US$47.088 billion, marking a slight year-on-year increase of 0.38%. Exports amounted to US$26.632 billion, up 4.39% year-on-year, primarily driven by […]<\/p>","protected":false},"author":4,"featured_media":616,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[62],"tags":[],"class_list":["post-599","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-industry-dynamics"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/posts\/599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/comments?post=599"}],"version-history":[{"count":0,"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/posts\/599\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/media\/616"}],"wp:attachment":[{"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/media?parent=599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/categories?post=599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.medicalsoho.com\/el\/wp-json\/wp\/v2\/tags?post=599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}